701637

Albert Q. Tejada — FEI 3008472469

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 14, 2010
Fiscal Year
2011
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Scottsdale, AZ (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance